For Industry
At DSF, we are committed to accelerating the development of effective treatments—and ultimately a cure—for Dravet syndrome and related epilepsies. Our assertive, collaborative approach brings together families, researchers, clinicians, and industry leaders to drive innovation forward as quickly and safely as possible.
Industry partners are a vital part of this effort.
Your expertise, resources, and dedication play a critical role in ensuring that promising therapies don’t stall in preclinical or early clinical stages—particularly in the high-risk “valley of death” in drug development. We believe that moving potential treatments from the lab to the clinic requires not only rigorous science but also strong, cross-sector partnerships.
That’s why DSF actively fosters collaboration with biopharmaceutical companies, device developers, and other stakeholders committed to improving outcomes for patients with Dravet syndrome.
Whether you are exploring preclinical studies, seeking clinical trial engagement, or looking to partner with a trusted patient organization, we are here to help.
Learn More About DSF-Industry Partnerships
Stay Connected